Our keynote speakers
Michael Gwynn
Director, Microbiology, Infectious Diseases CEDD
GlaxoSmithKline
Neil Ryder
Executive Director, Infectious Diseases
Novartis Institutes for Biomedical Research
Erin Duffy
Vice President, Discovery Research
Rib-X Pharmaceuticals
David Wareham
Clinical Senior Lecturer & Honorary Consultant, Centre for Infectious Disease
Barts and The London School of Medicine and Dentistry
Penny Heaton
Head of Clinical Research and Development Clusters
Novartis Vaccines and Diagnostics
Chandresh Harjivan
Director
PRTM
|
Our expert speakers
Alexander O'Neill, Independent Research Fellow, Institute of Molecular and Cellular Biology, University of Leeds
Anna Lönnroth, Infectious Diseases Unit, DG Research, European Commision
Barry Hafkin, Chief Medical Officer, Affinium Pharmaceuticals
Bozena Korczak, Senior Vice President, Chief Development Officer, PolyMedix
Chester Metcalf, VP, Discovery Chemistry, Cubist Pharmaceuticals
Colin Fishwick, Professor of Medicinal Chemistry, School of Chemistry, University of Leeds
Edmund Moran, Vice President, R&D Project Leader, Theravance
Fred Tenover, Senior Director, Cepheid
Helga Rübsamen-Schaeff, CEO, AiCuris
Jacques Dumas, Associate Director, Infection Chemistry, AstraZeneca
Laurent Fraisse, Head of Infectious Disease Research, Sanofi-Aventis
Malcolm Page, Head of Biology, Basilea Pharmaceutica
Michael Rudolf, Chief Scientific Officer, Kenta Biotech
Nachum Kaplan, Vice President, Microbiology, Affinium Pharmaceuticals
Richard Scott, Vice President, Research, PolyMedix
William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center
|